Case CRS (2501)
Cleveland, Ohio 44106
2 studies enrolling now · 20 studies all time
What they study most
HIV I Infection, HIV Infection, HIV Infections, HIV-1 Infection, HIV-1-infection, Hepatitis C, Liver Diseases, Menopause
Studies at this site
- Menopausal HT for Women Living With HIV (HoT) — Recruiting now
- Observational PIC Destination Cohort — Recruiting now
- Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy — Stopped early
- Doravirine for Obese Persons on Integrase Inhibitors and Tenofovir Alafenamide — Completed
- PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332) — Completed
- Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen — Completed
- Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection — Completed
- Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) — Completed
- Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells — Completed
- Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers — Completed
- Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults — Completed
- High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART — Completed
- Sevelamer for Reducing Endotoxemia and Immune Activation — Completed
- Rifaximin as a Modulator of Microbial Translocation and Immune Activation — Completed
- Sitagliptin for Reducing Inflammation and Immune Activation — Completed
- Modulation of Immune Activation by Aspirin — Completed
- Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate — Completed
- Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load — Completed
- Chloroquine for Reducing Immune Activation in HIV- Infected Individuals — Completed
- Examining the Incidence of Oral Human Papillomavirus (HPV) Shedding and Oral Warts After Beginning HAART in HIV-Infected Adults — Completed